To examine whether inhibition of the STING signaling can prevent obesity-induced inflammation in obesity, we treated mice with a STING inhibitor C-176 or vehicle via intraperitoneal injections once every other day for 9 weeks starting from 14-week HFD feeding. Here, STING1 is linked to obesity disorder.